McCourt Marion 4
4 · REGENERON PHARMACEUTICALS, INC. · Filed Dec 10, 2024
Insider Transaction Report
Form 4
McCourt Marion
SVP Commercial
Transactions
- Tax Payment
Common Stock
2024-12-09$787.00/sh−274$215,638→ 14,989 total - Award
Common Stock
2024-12-06+2,332→ 15,263 total - Award
Non-Qualified Stock Option (right to buy)
2024-12-06+8,981→ 8,981 totalExercise: $771.64Exp: 2034-12-06→ Common Stock (8,981 underlying)
Holdings
- 174(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 6, 2026 and 50% on December 6, 2028.
- [F2]The stock option award vests in four equal annual installments, commencing one year after the date of grant.